SACRAMENTO – Gov. Arnold Schwarzenegger on Wednesday said his administration will sue the Environmental Protection Agency if it fails to act more quickly on California’s request to regulate greenhouse gas emissions from automobiles. Schwarzenegger said he called EPA Administrator Stephen Johnson on Wednesday and told him his agency was moving too slowly on California’s 2005 request for a waiver to the federal Clean Air Act. The waiver, if granted by the EPA, would allow California to more aggressively regulate greenhouse gases as air pollutants. “If we don’t see quick action from the government, we will sue the U.S. EPA,” Schwarzenegger said during a luncheon speech in Beverly Hills, addressing the Milken Institute’s annual global conference. The administration’s letter announcing the intent to sue, a procedural step that is required six months before a lawsuit would be filed, was sent to the EPA on Wednesday, Schwarzenegger spokesman Aaron McLear said. The EPA had delayed acting because the agency maintained it did not have the authority to regulate the gases that contribute to global warming. 160Want local news?Sign up for the Localist and stay informed Something went wrong. Please try again.subscribeCongratulations! You’re all set!
India cricket team captain Virat Kohli obliged to fans’ requests of selfies and autographs during the team’s first training session ahead of the 3-match T20I series against West Indies in Florida.A group of passionate Indian cricket fans turned up at the Central Broward Regional Park Stadium Turf Ground in Lauderhill to see the Indian cricket team go through its training drills. Virat Kohli led the team during the session as the India stars played footvolley even as the bunch of fans watched on.Kohli made sure the India fans didn’t go home empty-handed as he took time out to interact with them. From signing autographs on t-shirts and on phone cases from obliging to requests of selfies, the India captain put a smile on the fans’ faces.Skipper @imVkohli does know how to bring smiles and joy to the fans #TeamIndia pic.twitter.com/lqrAUaCODYBCCI (@BCCI) August 1, 2019When it’s play ball time #TeamIndia pic.twitter.com/EPMNJsiCseBCCI (@BCCI) August 1, 2019India will play two T20Is in Florida on August 3 and 4 before heading to Guyana for the final T20I of the 3-match series against the West Indies. Virat Kohli’s men will then play 3 ODIs before kicking off their world championships campaign with a 2-Test series against the West Indies.A lot of fresh faces have been inducted into the senior national team for the limited-overs series against the West Indies. MS Dhoni was not available for selection as the veteran wicketkeeper-batsman has taken a 2-month break from international cricket to train with the Parachute Regiment of the Indian Army.advertisementOn the other hand, the likes of Shreyas Iyer and Manish Pandey have been handed recalls as India will be looking to settle their middle order issues that hampered their performances at World Cup 2019. Seasoned wicketkeeper-batsman Dinesh Karthik faced the axe after India’s semi-final defeat to New Zealand in England last month.Amid rumours of rift in the Indian camp, the Virat Kohli-led team left for Florida. The India captain rubbished the rumours of strain in his relationship with limited-overs vice-captain Rohit Sharma. Speculations were rife that Kohli and Rohit were not on the same page when it came to the on-field issues and the latter’s Instagram activity wherein he reportedly unfollowed Anushka Sharma added fuel to fire.”In my opinion it’s baffling to be honest. It’s absolutely ridiculous to read such stuff that comes out. I have been to a few public events and the sentiment is ‘aap log kya khele (you guys played so well)’,” Virat Kohli said at India’s pre-departure press conference on Monday.”We are feeding off lies. We are overlooking facts. We are turning a blind eye to all the good things that has happened. We are creating fantasies and scenarios in our head and want to accept that this is the truth,” Kohli added.Also Read | Virat Kohli enjoys Miami outing with Anushka Sharma ahead of West Indies tourAlso Read | Ashes 2019: Steve Smith 2nd fastest after Don Bradman to hit 24 Test hundredsAlso See:
AddThis ShareCONTACT: Jade BoydPHONE: 713-348-6778E-MAIL: [email protected], TMC team take aim at pancreatic cancerNational Cancer Institute funds preclinical ‘theranostic’ studyResearchers from Rice University’s Laboratory for Nanophotonics (LANP), the radiology department at Baylor College of Medicine (BCM) and the University of Texas MD Anderson Cancer Center are preparing to test a combined approach for diagnosing and treating pancreatic cancer with a specially engineered nanoparticle. The five-year, preclinical testing program will be funded by a newly announced $1.8 million grant from the National Cancer Institute’s (NCI) Alliance for Nanotechnology in Cancer program.“Pancreatic cancer is notoriously difficult to treat, and we hope nanoparticle-based ‘theranostics’ can change that,” said LANP Director Naomi Halas, Rice’s Stanley C. Moore Professor in Electrical and Computer Engineering and professor of chemistry and biomedical engineering. “Our nanoparticles are designed to specifically target cancer cells and to function as both diagnostic and therapeutic agents.”Pancreatic cancer is one of the most deadly forms of cancer. Surgery is often the only treatment option, and the five-year, postsurgical survival rate is less than 25 percent.Halas is the inventor of gold nanoshells, tiny gold-sheathed particles that can harvest light and convert it to heat. She also helped pioneer the use of nanoshells for cancer treatment, and she is the principal investigator on the new NCI grant. The theranostic project team includes co-principal investigators Amit Joshi, assistant professor of radiology at BCM; Sunil Krishnan, associate professor in radiation oncology at MD Anderson; and Peter Nordlander, professor of physics and astronomy at Rice.Theranostics involve technologies and agents that can diagnose and treat diseases in a single procedure. The theranostic particle that will be tested at Rice, BCM and MD Anderson was invented at LANP.“A seamless integration of multiple imaging and therapeutic technologies within a single nanoparticle is required to tackle diseases like pancreatic cancer, which often resist conventional therapies,” Joshi said.At the heart of the particle is a nanoshell that can be used to kill cancer cells with heat. The particle can also be tagged with antibodies that allow it to home in on specific types of cancer cells. In addition, the nanoparticle is designed to provide high-resolution images regarding its location in the body and in the tumor. This is accomplished by combining an FDA-cleared dye for fluorescence imaging with an active marker for MRI imaging. These combined capabilities allow researchers to track the nanoparticles throughout the body and even observe their distribution within the tumor before, during and after treatment.“This level of highly detailed information on nanoparticle location in the body has not been obtainable previously,” Halas said.In the first published tests of the new particle last year, Joshi, Halas and colleagues showed it could be used to simultaneously detect and destroy breast and ovarian cancer cells in cell cultures.In the NCI study, researchers will test whether the particles can be used to image and treat pancreatic cancer in mice. The tests will investigate how well the particles work as imaging agents — both in MRI scans and in fluorescent optical scans, how well they target specific cell types, where they go inside the body after testing and treatment and how well they perform as therapeutic agents. In addition, Krishnan’s lab at MD Anderson has a particular interest in testing the particles to see if they can be used to boost the effectiveness of radiation therapy.“Nanoparticle-based theranostics holds great promise, not only for treating pancreatic cancer, but for treating other forms of cancer as well,” Halas said. “But successfully translating new technology like this from the lab to the clinic requires excellent research partnerships, like those we have at Baylor College of Medicine and MD Anderson.”The Laboratory for Nanophotonics at Rice was formed in 2004 with the mission to invent, understand, develop, simulate, control, optimize and apply nanoscale optical elements, components and systems. LANP features a strong interdisciplinary research program in three primary areas: metal-based plasmonics, nanoparticle-enhanced sensing and spectroscopy, and nanophotonic applications in biomedicine.